Oxford Therapeutics Consulting Limited Report issue

For profit Phase 1 Phase 2
Founded: Crowthorne Berks United Kingdom (1992)

Organization Overview

First Clinical Trial
2015
NCT02572635
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Oxford Therapeutics Consulting

Active Ingredients

Drugs in Phase 2 Trials (1)

dimethyltryptamine (1 trial)

Drugs in Phase 1 Trials (1)

pnubiovax (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Pneumococcal Infections (Phase 1)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 2
  • # of Trial APIs: 2